Wuhan Keqian Biology Co Ltd (688526) — Cash Flow Reinvestment Rate
Wuhan Keqian Biology Co Ltd (688526) has a Cash Flow Reinvestment Rate of 0.07x as of September 2025, reinvesting CN¥11.35 Million (capex CN¥11.35 Million ) from operating cash flow of CN¥174.36 Million. Explore 688526 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Wuhan Keqian Biology Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Wuhan Keqian Biology Co Ltd across 9 annual periods. Also explore Wuhan Keqian Biology Co Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Wuhan Keqian Biology Co Ltd. For live market cap and broader valuation context, see 688526 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.78x | CN¥307.88 Million | CN¥392.68 Million | CN¥106.94 Million | ▼ -2.7% |
| 2023 | 0.81x | CN¥433.50 Million | CN¥538.03 Million | CN¥104.50 Million | ▼ -53.9% |
| 2022 | 1.75x | CN¥739.98 Million | CN¥423.71 Million | CN¥102.85 Million | ▲ +31.5% |
| 2021 | 1.33x | CN¥705.55 Million | CN¥531.27 Million | CN¥374.45 Million | ▼ -59.2% |
| 2020 | 3.25x | CN¥1.30 Billion | CN¥400.14 Million | CN¥111.60 Million | ▼ -33.8% |
| 2019 | 4.92x | CN¥761.46 Million | CN¥154.89 Million | CN¥137.74 Million | ▲ +5404.8% |
| 2018 | 0.09x | CN¥31.42 Million | CN¥351.83 Million | CN¥31.42 Million | ▼ -76.6% |
| 2017 | 0.38x | CN¥129.11 Million | CN¥337.61 Million | CN¥129.11 Million | ▲ +189.7% |
| 2016 | 0.13x | CN¥29.13 Million | CN¥220.69 Million | CN¥29.13 Million | — |